Clinical Trials on Фебрильная нейтропения
Total 0 results
Nothing found
Sponsors and Collaborators
- S-Biotek Holding ApS
- University of Applied Sciences Jena
- 904 Hospital of the People's Liberation Army Joint Logistic Support Force
- Lilly PharmaceuticalCompany
- Korea Otsuka International Asia Arab
- Cardiovascular Center Dedinje, Belgrade, Serbia
- Julian Taylor Green
- Foshan Sanshui District People's Hospital
- United States Department of Defense (DOD)
- Oblikue Consulting
- Rivierduinen, Centre for Personality disorders Jelgersma
- Gunkang Pharmaceuticals, Inc
- Paulo Sérgio Gomes Nogueira Borges
- Iyad Naeem Muhammad, PhD
- Foundation for Biosanitary Research and Innovation in Primary Health Care
- Sudimplant SAS - Groupe TBR
- Eurotrials Brasil Consultores Cientificos Ltda
- Arsha Vidya Tirtha
- Plethora Solutions Ltd
- Klinik für Allgemein- und Viszeralchirurgie, Department Chirurgie, Luzerner Kantonsspital
- View Full List
Medical Conditions
- Advance Directive Completion
- Gray Platelet Syndrome
- Deformity Flexion
- Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
- Brain Tumor, Primary
- Vibration; Exposure
- Testicular Teratoma
- Visual Attention Span Deficit
- Huntington Chorea
- Malaria,Falciparum
- Chemotherapy-Induced Neutropenia
- Post-discharge Pharmacist Counseling to Prevent Readmissions
- Immunologically-induced Lung Disease
- Puberty, Delayed
- Relapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)
- Hypothermia Following Anesthesia, Sequela
- Thyroid and Parathyroid Surgery
- Serum Albumin Low
- Anemia Acute
- Blepharospasm of Both Eyelids
- View Full List
Drug Interventions
- Ebselen
- Cytisine
- Bimatoprost 0.03% eye drops
- Oxycodone
- Standard medical therapy
- MMV390048 120mg
- Pemetrexed
- Cyanoacrylate
- Recombinant monoclonal antibody against human epidermal growth factor receptor injection (HS627)
- S-Adenosyl-Methionine
- Celecoxib
- F520
- ABY-035 i.v.
- Rovalpituzumab tesirine
- Acalabrutinib in combination with VR
- Mineralocorticoid receptor antagonist
- Furmonertinib 160 mg
- Vosaroxin
- Pegfilgrastim
- Sorafenib
- View Full List
CROs by country
- Contract Research Organizations in Argentina
- Contract Research Organizations in Bahamas
- Contract Research Organizations in Burkina Faso
- Contract Research Organizations in Germany
- Contract Research Organizations in Hungary
- Contract Research Organizations in Liberia
- Contract Research Organizations in Madagascar
- Contract Research Organizations in Malaysia
- Contract Research Organizations in Mozambique
- Contract Research Organizations in New Zealand
- Contract Research Organizations in Rwanda
- Contract Research Organizations in Sweden
- Contract Research Organizations in Vietnam
- CRO list by country